Market Overview:
The global veterinary pain management drugs market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for pain relief drugs in animals, rising awareness about animal health and welfare, and growing number of veterinary clinics and hospitals. The global veterinary pain management drugs market is segmented on the basis of type into opioids, α2-adrenergic agonists, local anesthetics, nonsteroidal anti-inflammatory drugs (NSIDs), sedatives, corticosteroids, and others. The opioids segment is expected to account for the largest share of the global veterinary pain management drugs market in 2018. This segment is projected to grow at a CAGR of 6% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to its high efficacy in relieving moderate-to-severe pain in animals as well as its easy availability through retail pharmacies across regions. On the basis of application, the global veterinary pain management drugs market is divided into Veterinary Hospitals, Veterinary Clinics For Retail Sale ,and Others .
Product Definition:
Veterinary pain management drugs are medications used to alleviate pain in animals. They may be prescribed for short-term or long-term use, depending on the nature of the animal's condition. Pain management is important because it can improve an animal's quality of life and help them recover from surgery or an illness.
Opioids:
Opioids are natural substances produced in the body as well as synthetic drugs that are used to treat pain. Opioids act on ovoid receptors to produce morphine like effects which include euphoria, relaxation and nausea reduction. The most commonly used opioids in veterinary medicine include codeine, hydrocodone, oxycodone and fentanyl. Other than human use, opioids also have uses in animal health including treatment of acute pain (e.g.
α2-Adrenergic Agonists:
α2-adrenergic agonists are used to treat diseases associated with abnormal heart rhythms. They work by increasing the force of contraction of cardiac muscle, which helps to normalize the heartbeat. The drugs can be administered through a vein or by mouth and they are quickly absorbed into the bloodstream.
Application Insights:
The application segment includes veterinary hospitals, clinics and other locations where the drugs are used for pain management in animals. The use of these drugs in this setting is mainly driven by the availability of veterinarians skilled in pain management to treat animals with chronic or acute injuries. In addition, factors such as increasing animal ownership rates coupled with rising awareness among pet owners regarding proper treatment for animal injuries are expected to drive demand over the forecast period.
The veterinary clinic segment accounted for a significant share of around 40% in 2017 owing to increased government funding and support towards establishing new clinics across rural areas or less-developed regions where there is a high prevalence rate of livestock farming activities.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high pet ownership rate, and rapid technological advancements are some of the key factors contributing to its growth. Moreover, increasing demand for pet insurance is also propelling regional growth.
Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to rising disposable income and growing awareness about veterinary health among people and animals coupled with government initiatives such as “One Health†program implemented in China since 2014 that aims at improving animal health across all species including humans has led many foreign companies such as Merck KGaA; PetAgrees Inc.
Growth Factors:
- Increasing demand for pain relief drugs in veterinary sector owing to the increasing number of surgeries and rising awareness about pain management among pet owners.
- Growing prevalence of chronic diseases in pets, such as arthritis and cancer, which leads to increased demand for pain relief drugs.
- Rising adoption of companion animals, especially dogs and cats, across the globe is expected to boost the market growth during the forecast period.
- Technological advancements in veterinary analgesics that offer better efficacy and safety profiles are likely to propel the market growth over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Veterinary Pain Management Drugs Market Research Report
By Type
Opioids, α2-Adrenergic Agonists, Local Anesthetics, Nonsteroidal Anti-Inflammatory Drugs (NSIDs), Sedatives, Corticosteroids, Others
By Application
Veterinary Hospitals, Veterinary Clinics, For Retail, Others
By Companies
Boehringer Ingelheim, Merck & Co, Zoetis, Elanco, Bayer Pharma AG, Ceva Sante Animale, Norbrook Laboratories, Baxter, Halyard, Bostonscientific, Boehringer Ingelheim, Endo International, Forest Laboratories, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Veterinary Pain Management Drugs Market Report Segments:
The global Veterinary Pain Management Drugs market is segmented on the basis of:
Types
Opioids, α2-Adrenergic Agonists, Local Anesthetics, Nonsteroidal Anti-Inflammatory Drugs (NSIDs), Sedatives, Corticosteroids, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary Hospitals, Veterinary Clinics, For Retail, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Merck & Co
- Zoetis
- Elanco
- Bayer Pharma AG
- Ceva Sante Animale
- Norbrook Laboratories
- Baxter
- Halyard
- Bostonscientific
- Boehringer Ingelheim
- Endo International
- Forest Laboratories
- Medtronic
Highlights of The Veterinary Pain Management Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Opioids
- α2-Adrenergic Agonists
- Local Anesthetics
- Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
- Sedatives
- Corticosteroids
- Others
- By Application:
- Veterinary Hospitals
- Veterinary Clinics
- For Retail
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Veterinary Pain Management Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Veterinary pain management drugs are medications used to relieve pain in animals. They can be prescribed by a veterinarian to treat a variety of conditions, including arthritis, cancer, dental pain, and injuries.
Some of the key players operating in the veterinary pain management drugs market are Boehringer Ingelheim, Merck & Co, Zoetis, Elanco, Bayer Pharma AG, Ceva Sante Animale, Norbrook Laboratories, Baxter, Halyard, Bostonscientific, Boehringer Ingelheim, Endo International, Forest Laboratories, Medtronic.
The veterinary pain management drugs market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Veterinary Pain Management Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Veterinary Pain Management Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Veterinary Pain Management Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Veterinary Pain Management Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Veterinary Pain Management Drugs Market Size & Forecast, 2020-2028
4.5.1 Veterinary Pain Management Drugs Market Size and Y-o-Y Growth
4.5.2 Veterinary Pain Management Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Opioids
5.2.2 α2-Adrenergic Agonists
5.2.3 Local Anesthetics
5.2.4 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
5.2.5 Sedatives
5.2.6 Corticosteroids
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Veterinary Hospitals
6.2.2 Veterinary Clinics
6.2.3 For Retail
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Veterinary Pain Management Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Veterinary Pain Management Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Opioids
9.6.2 α2-Adrenergic Agonists
9.6.3 Local Anesthetics
9.6.4 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
9.6.5 Sedatives
9.6.6 Corticosteroids
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Veterinary Hospitals
9.10.2 Veterinary Clinics
9.10.3 For Retail
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Opioids
10.6.2 α2-Adrenergic Agonists
10.6.3 Local Anesthetics
10.6.4 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
10.6.5 Sedatives
10.6.6 Corticosteroids
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Veterinary Hospitals
10.10.2 Veterinary Clinics
10.10.3 For Retail
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Opioids
11.6.2 α2-Adrenergic Agonists
11.6.3 Local Anesthetics
11.6.4 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
11.6.5 Sedatives
11.6.6 Corticosteroids
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Veterinary Hospitals
11.10.2 Veterinary Clinics
11.10.3 For Retail
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Opioids
12.6.2 α2-Adrenergic Agonists
12.6.3 Local Anesthetics
12.6.4 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
12.6.5 Sedatives
12.6.6 Corticosteroids
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Veterinary Hospitals
12.10.2 Veterinary Clinics
12.10.3 For Retail
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Opioids
13.6.2 α2-Adrenergic Agonists
13.6.3 Local Anesthetics
13.6.4 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
13.6.5 Sedatives
13.6.6 Corticosteroids
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Veterinary Hospitals
13.10.2 Veterinary Clinics
13.10.3 For Retail
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Veterinary Pain Management Drugs Market: Competitive Dashboard
14.2 Global Veterinary Pain Management Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim
14.3.2 Merck & Co
14.3.3 Zoetis
14.3.4 Elanco
14.3.5 Bayer Pharma AG
14.3.6 Ceva Sante Animale
14.3.7 Norbrook Laboratories
14.3.8 Baxter
14.3.9 Halyard
14.3.10 Bostonscientific
14.3.11 Boehringer Ingelheim
14.3.12 Endo International
14.3.13 Forest Laboratories
14.3.14 Medtronic
